There is a major role for telehealth in oncology care, not only for its convenience but also for giving clinicians the ability to scale nononcologic visits, explained Emeline Aviki, MD, MBA, FACOG, assistant attending gynecologic cancer surgeon at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and lead of the MSKCC Affordability Working Group.
In an interview at our September Institute for Value-Based Medicine® event in New York City, Emeline Aviki, MD, MBA, FACOG, assistant attending gynecologic cancer surgeon at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and lead of the MSKCC Affordability Working Group, discussed how benefits of telehealth in oncologic care extend to other specialty care for patients.
Transcript
What role does telehealth play in oncology care?
Telehealth has a major role in cancer care. I think the COVID-19 pandemic showed us how valuable telehealth can be, not only for patient convenience, but also to make sure that patients are compliant with follow-up. Telehealth can offer a lot of convenience for patients.
If you have a follow-up visit with a patient where they don't need a physical exam and they can get their labs at a time that's convenient for them, that's the perfect opportunity to not force them to have to pay for parking [and] take a day off work. Just take a break during work, do your visit with your oncologist, and get back to life.
In addition to offering patients convenient oncology visits, it also offers the ability to scale nononcologic visits that are very helpful for patients; for example, psychiatric care, supportive care for pain management. It would allow you to get those services that are really in shortage to patients no matter where they are.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More